Dr Albigès on the Efficacy of Cabozantinib in Pretreated RCC

Laurence Albigès, MD, PhD, discusses on the safety and efficacy of cabozantinib in patients with unresectable, locally advanced or metastatic renal cell carcinoma with a clear cell component.

Related Keywords

France ,Laurence Albig ,Gustave Roussy Institute ,Department Of Medicaloncology ,Rcc Database Consortium ,Genitourinary Unit ,Onclive Tv ,Genitourinary Cancers ,